SCHEMBL23773091

SCHEMBL23773091

C=C(CCCNC(=O)Nc1ccc(Cl)c(Cl)c1)NC(=O)COc1ccc(Cl)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ GRIN1 Q05586 4/20 0.45
▸ GRIN2B Q13224 4/20 0.45
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ SLC2A1 P11166 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ATF4 P18848 5/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23773254 0.85 ATF4 (0.46) LMNAMAPK1NPC1HPGDRAB9A
SCHEMBL20999062 0.81 ALDH1A1 (0.50) GRIN1GRIN2BMEN1KMT2AATF4
SCHEMBL22669006 0.80 HTT (0.49) GRIN1GRIN2BMEN1KMT2AATF4
SCHEMBL23773238 0.79 ATF4 (0.45) LMNANPC1HPGDRAB9AMEN1
SCHEMBL20999659 0.78 ALDH1A1 (0.47) GRIN1GRIN2BMEN1KMT2AATF4
SCHEMBL22669399 0.78 MAPT (0.41) LMNANPC1RAB9AATF4MAPT
SCHEMBL25797240 0.78 ATF4 (0.48) LMNAATF4ALDH1A1
SCHEMBL23773237 0.77 NPC1 (0.48) LMNAMAPK1NPC1HPGDRAB9A
SCHEMBL22669609 0.77 ALDH1A1 (0.46) LMNAGRIN1GRIN2BATF4ALDH1A1
SCHEMBL22669308 0.77 ATF4 (0.48) GRIN1GRIN2BMEN1KMT2AATF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253528-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253528-A1 CHEMICAL COMPOUNDS ATF4, EIF2AK4, ATF1 LMNA 1064/4885MAPK1 358/4885NPC1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback